Antitumor activity of a novel quinoline derivative, TAS-103, with inhibitory effects on topoisomerases I and II.
about
A novel cinnamic acid derivative that inhibits Cdc25 dual-specificity phosphatase activity.Novel acridine-based compounds that exhibit an anti-pancreatic cancer activity are catalytic inhibitors of human topoisomerase II.Modular o-quinone catalyst system for dehydrogenation of tetrahydroquinolines under ambient conditions.Novel chloroquinoline derivatives incorporating biologically active benzenesulfonamide moiety: synthesis, cytotoxic activity and molecular docking.The geometry of DNA supercoils modulates topoisomerase-mediated DNA cleavage and enzyme response to anticancer drugs.Discovery of indeno[1, 2 - c] quinoline derivatives as dual topoisomerases I/II inhibitors: part 3.Anticancer activity of novel indenopyridine derivatives.Chiral ruthenium(II) anthraquinone complexes as dual inhibitors of topoisomerases I and II.4-Amino-3-acetylquinoline-induced apoptosis of murine L1210 leukemia cells involves ROS-mitochondrial-mediated death signaling and activation of p38 MAPK.Leptosins isolated from marine fungus Leptoshaeria species inhibit DNA topoisomerases I and/or II and induce apoptosis by inactivation of Akt/protein kinase B.Mechanism of apoptosis induced by a new topoisomerase inhibitor through the generation of hydrogen peroxide.Establishment and characterization of 6-[[2-(Dimethylamino)ethyl]amino]-3-hydroxy-7H-indeno[2,1-c]quinolin-7-one dihydrochloride (TAS-103)-resistant cell lines.A dual topoisomerase inhibitor, TAS-103, induces apoptosis in human cancer cells.Effect of phenazine compounds XR11576 and XR5944 on DNA topoisomerases.Dual inhibition of topoisomerases I and IIα by ruthenium(II) complexes containing asymmetric tridentate ligands.In vitro antitumor activity of TAS-103, a novel quinoline derivative that targets topoisomerases I and II.Synthesis and antiproliferative evaluation of 9-methoxy-6-(piperazin-1-yl)-11H-indeno[1,2-c]quinoline-11-one derivatives. Part 4
P2860
Q33222512-DFFAAF12-EC42-4599-9BDB-15F060974192Q33391858-319F207D-98B3-47BB-8AE0-0686969147B2Q34120267-D66364C4-4DBF-4B4D-BB46-5095F95B3066Q36769323-C4200BB6-7862-4DA0-BA06-8E9E8D32A3A9Q36839637-528D76DC-1699-4083-B2B2-69CB4063664CQ39097637-4BC328BC-753E-4AFB-BCCF-470E91968FC0Q39301178-32DAA467-C008-4A44-A5D7-F0C537D1CA2EQ39486529-038E0949-8644-42BB-94D6-D4967C84D56EQ39977692-5873EC6C-A6C3-4D97-84AB-3D1FAB3AD18FQ40354649-B7A0F371-B6CC-4C54-B6B4-4C4BAAB848CCQ40724539-D746BE78-5202-4846-8CC2-F97E9B1D4CACQ40876344-B4808832-35ED-4DB4-A5C3-07720CC36892Q40938391-2A144488-9D86-4B58-9E63-7C9B00344B7DQ46446314-41B8A4D3-F8D5-4B9D-9A36-428C48E45BC4Q53414064-D32AE8D0-3F5C-428E-8180-A63E4385871FQ54959930-92A0B5AE-B719-420C-97AB-78FECB50A004Q57236117-20B6534C-A73A-4995-994D-52071FC16EF8
P2860
Antitumor activity of a novel quinoline derivative, TAS-103, with inhibitory effects on topoisomerases I and II.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Antitumor activity of a novel ...... ts on topoisomerases I and II.
@en
Antitumor activity of a novel ...... ts on topoisomerases I and II.
@nl
type
label
Antitumor activity of a novel ...... ts on topoisomerases I and II.
@en
Antitumor activity of a novel ...... ts on topoisomerases I and II.
@nl
prefLabel
Antitumor activity of a novel ...... ts on topoisomerases I and II.
@en
Antitumor activity of a novel ...... ts on topoisomerases I and II.
@nl
P2093
P2860
P1476
Antitumor activity of a novel ...... ts on topoisomerases I and II.
@en
P2093
P2860
P304
P356
10.1111/J.1349-7006.1997.TB00320.X
P577
1997-10-01T00:00:00Z